MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-18-0002264
Mahima Lifesciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹177.98 Cr
▼ 18% YoY
Net profit · FY 2025
₹6.08 Cr
Net margin 3.4%
EBITDA · FY 2025
₹9.22 Cr
EBITDA margin 5.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹59.91 Lakh
Issued & subscribed
Open charges
₹45.25 Cr
Satisfied ₹2.5 Cr
Company age
30 yrs
Est. 1996
Employees · EPFO
33
Provident fund records
About Mahima Lifesciences Private Limited
Data last updated:
Mahima Lifesciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51311DL1996PTC083943. Its GSTIN is 07AAACM6962E2ZG (Delhi). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹59.91 Lakh. It was formerly known as Mahima Exports Private Limited. It is led by directors Pramod Mittal and Rajeev Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6A 6th Floor Big Jos Tower, A – 8 Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹177.98 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹6.08 Cr (net margin 3.4%) and EBITDA of ₹9.22 Cr (EBITDA margin 5.2%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mahima Life Sciences. As per MCA filings, the company has open charges of ₹45.25 Cr and satisfied charges of ₹2.5 Cr on record. Court records list 23 cases involving the company, including 13 filed by the company and 10 filed against it; 7 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹18.57 Cr; the latest was in April 2015. Its 10 peer companies in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Shree Jaya Laboratories Private Limited with revenue of ₹186.81 Cr. The company has 8 MSME Form 1 returns on record between 2019 and 2022, listing 63 overdue payments to 23 micro and small suppliers.
Mahima Lifesciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0002264). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mahimalife.com.
Company details
CIN U51311DL1996PTC083943
Registration Number 083943
Incorporation Date 19 December 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-18-0002264
Key People
Pramod Mittal Director Rajeev Goel Director Recognitions & Rankings of Mahima Lifesciences
Contact details
Mahima Lifesciences Private Limited's registered office is in Delhi, Delhi. Its website is mahimalife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address6A 6th Floor Big Jos Tower, A – 8 Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mahima Lifesciences Private Limited, buy the company report.
Comprehensive company report
Mahima Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mahima Lifesciences operates one associated brand: Mahima Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Research-based company manufacturing corticosteroids, APIs, vitamins for international and domestic markets. | mahimalife.com |
Business activity
The main business activity of Mahima Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mahima Lifesciences Private Limited, buy the company report.
Financials of Mahima Lifesciences Private Limited
FY 2025 filings availableMahima Lifesciences Private Limited reported revenue of ₹177.98 Cr (down 18% YoY) for FY 2025.
Revenue · FY 2025
₹177.98 Cr ▼ 18%
Net profit · FY 2025
₹6.08 Cr margin 3.4%
EBITDA · FY 2025
₹9.22 Cr margin 5.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 1%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 23%
5 years · compounded
▼ 22%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 18% fall in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.08 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mahima Lifesciences Private Limited, buy the company report.
Board of directors of Mahima Lifesciences Private Limited
Mahima Lifesciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Mittal Also directs: Gatimaan Developers LLP | Director | 12 Jun 2006 | 20 Years 4 Months | Current |
| Rajeev Goel | Director | 01 Jun 2011 | 15 Years 4 Months | Current |
Peer comparison
Mahima Lifesciences Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shree Jaya Laboratories Private Limited | ₹186.81 Cr (FY 2025) | -9.0% | Telangana, India | |||
| Multi Organics Private Limited | ₹185.7 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Virchow Drugs Limited | ₹185.43 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India | |||
| GMFC Labs Private Limited | ₹179.23 Cr (FY 2025) | 106.0% | Hyderabad, Telangana, India | |||
| Chandak Laboratories Private Limited | ₹178.82 Cr (FY 2024) | -26.0% | Hyderabad, Telangana, India | |||
| Mahima Lifesciences Private Limitedthis company | ₹177.98 Cr (FY 2025) | ₹6.08 Cr | 3.4% | -18.0% | 33 | Delhi, India |
| BDR Lifesciences Private Limited | ₹176.87 Cr (FY 2025) | -5.0% | Vadodara, Gujarat, India | |||
| Infinity Laboratories Private Limited | ₹176.27 Cr (FY 2025) | -26.0% | Derabassi, Punjab, India | |||
| Elppe Chemicals Private Limited | ₹173.94 Cr (FY 2024) | 8.0% | Raigad, Maharashtra, India | |||
| Enaltec Labs Private Limited | ₹169.73 Cr (FY 2025) | 11.0% | Thane, Maharashtra, India | |||
| Mac-Chem Products (India) Private Limited | ₹167.51 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mahima Lifesciences Private Limited, buy the company report.
Auditor
Mahima Lifesciences Private Limited is audited by S V P & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S V P & Associates | FY 2023 | 0003838N |
Shareholding
The shareholding of Mahima Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mahima Lifesciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹45.25 Cr
Satisfied charges
₹2.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Oct 2023 | 100803812 | Hdfc Bank Limited | ₹10.1 Cr | Open | |
| 18 Oct 2007 | 10083761 | Hdfc Bank Limited | ₹35.15 Cr | Open | |
| 27 Mar 2006 | 10002728 | Union Bank of India | ₹2.5 Cr | Satisfied |
To see the full charge records of Mahima Lifesciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Mahima Lifesciences Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹18.57 Cr; the latest was in April 2015.
Total deals
7
Secondary share transfers
4
Funding rounds
3
Disclosed funding
₹18.57 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Oct 2012 | Funding round | ₹10.64 Cr | Investors: Little Star Vintrade Private Limited |
| Mar 2012 | Funding round | ₹7.88 Cr | Investors: Encord Commercial Private Limited |
| Jul 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2009 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Spark Fincap Private Limited , Ora Paints and Chemicals Private Limited , Neelkanth Ayurved Private Limited |
To see the full deal history of Mahima Lifesciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mahima Lifesciences Private Limited has 23 court cases on record: 13 filed by Mahima Lifesciences, 10 filed against it. 7 cases are pending and 16 are disposed.
Total cases
23
Filed by the company
13
Filed against the company
10
Pending
7
Disposed
16
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 5 | 1 |
| NCLAT | 9 | 5 | 4 |
| High courts | 4 | 0 | 2 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Execution petition | Filed by the company against M/S Concept Biosciences Private Limited and 1 other | Pending |
| District court, North, Delhi | Criminal case | Filed by the company against Alpic Remedies Limited | Disposed |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against State of Haryana and Others | Pending |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed by the company against Ajay Kumar Agarwal Erstwhile Interim Resolution Professional in Concept Biosciences India Pvt. Ltd | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against M/S Radico Khaitan Limited | Pending |
To see the full case history of Mahima Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Mahima Lifesciences Private Limited has 8 MSME Form 1 returns on record between 2019 and 2022, listing 63 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Chemstar Global Products LLP | |||
| Pradipkumar Pharma Private Limited | |||
| Amit Speciality Gas Co.-Haryana | |||
| Amjey Chem Trade Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Mahima Lifesciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Mahima Lifesciences Private Limited has a workforce of 33 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
33
Active EPFO establishments
1
Employee growth
94.12%
GST
Mahima Lifesciences has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACM6962E2ZG | Delhi | Active | 26 May 2025 |
| 06AAACM6962E1ZJ | Haryana | Active | 01 Jul 2017 |
| 03AAACM6962E1ZP | Punjab | Active | 16 Mar 2022 |
To see the full GST registrations and return filing status of Mahima Lifesciences Private Limited, buy the company report.
Recent activity
Mahima Lifesciences Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Rajeev Goel ceased to be Additional Director on 30 Sep 2011.
AGM
Mahima Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 35.15 Cr registered on 18 Oct 2007 with Charge ID 10083761 was modified on 14 Jul 2025.
Filing
Mahima Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.10 Cr with Charge ID 100803812 was registered on 30 Oct 2023.
Ceased
Rajeev Goel ceased to be Additional Director.
Ceased
Sanjeev Goel ceased to be Director.
Appointed
Rajeev Goel was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 35.15 Cr with Charge ID 10083761 was registered on 18 Oct 2007.
Charges
A charge registered on 27 Mar 2006 via Charge ID 10002728 with Union Bank Of India was fully satisfied on 01 Oct 2007.
Appointed
Pramod Mittal was appointed as Director.
Charges
A charge with Union Bank Of India amounted to Rs. 2.50 Cr with Charge ID 10002728 was registered on 27 Mar 2006.
Incorporation
19 Dec 1996
Mahima Lifesciences Private Limited was registered on 19 Dec 1996 with Roc Delhi & aged 29 years 10 months as per MCA records.
Frequently asked questions
Mahima Lifesciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 December 1996 (30+ years old) and is registered under CIN U51311DL1996PTC083943.
Mahima Lifesciences has 2 current directors:
- Pramod Mittal - Director
- Rajeev Goel - Director
The latest financial statements of Mahima Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mahima Lifesciences is 07AAACM6962E2ZG, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 06AAACM6962E1ZJ (Haryana), 03AAACM6962E1ZP (Punjab).
The CIN (Corporate Identification Number) of Mahima Lifesciences is U51311DL1996PTC083943. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mahima Lifesciences has 23 court cases on record: 13 filed by the company and 10 filed against it. 7 are pending. Most are in the district courts.
Mahima Lifesciences was incorporated on 19 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
Mahima Lifesciences has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹18.57 Cr; the latest was in April 2015.
The peers of Mahima Lifesciences by revenue are Shree Jaya Laboratories Private Limited, Multi Organics Private Limited, Virchow Drugs Limited, GMFC Labs Private Limited, Chandak Laboratories Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajeev Goel ceased to be Additional Director on 30 Sep 2011. Sanjeev Goel ceased to be Director on 08 Jun 2011. Rajeev Goel was appointed as Director on 01 Jun 2011. Mahima Lifesciences has 4 board changes on record in total.
Yes, Mahima Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-18-0002264).
Mahima Lifesciences has 8 MSME Form 1 returns on record between 2019 and 2022, listing 63 overdue payments to 23 micro and small suppliers. The latest return was filed on 27 Apr 2022.